CCDC65 Gene Primary ciliary dyskinesia type 27 Genetic Test
Welcome to DNA Labs UAE, where we offer the CCDC65 Gene Primary ciliary dyskinesia type 27 Genetic Test. This test is designed to identify any variations or mutations in the CCDC65 gene that may be associated with primary ciliary dyskinesia type 27, a genetic disorder affecting the function of cilia in the body.
Test Details
The CCDC65 gene is responsible for primary ciliary dyskinesia type 27, a condition that affects the movement of mucus and other substances in various organs, including the respiratory tract and reproductive system. Our Next-Generation Sequencing (NGS) technology allows for the rapid analysis of multiple genes or even the entire genome, making it an effective tool for genetic testing.
Components and Price
The cost of the CCDC65 Gene Primary ciliary dyskinesia type 27 Genetic Test is AED 4400.0. The test can be conducted using either blood or extracted DNA samples, or even a single drop of blood on an FTA Card. The report will be delivered within 3 to 4 weeks.
Test Type and Doctor
The CCDC65 Gene Primary ciliary dyskinesia type 27 Genetic Test falls under the category of Ear Nose Throat Disorders. It is recommended to consult with an ENT Doctor for this test. Our Genetics department handles the testing process.
Pre Test Information
Before undergoing the CCDC65 Gene Primary ciliary dyskinesia type 27 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session is recommended to draw a pedigree chart of family members affected by the EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test gene EYA18.
Benefits of the Test
The CCDC65 Gene Primary ciliary dyskinesia type 27 Genetic Test can aid in the diagnosis of primary ciliary dyskinesia type 27, providing valuable information about the specific genetic cause of the condition. It is particularly useful for individuals with symptoms suggestive of the disorder or those with a family history of the condition. The test can help confirm a diagnosis, guide treatment decisions, and provide information about the risk of passing on the condition to future generations.
| Test Name | CCDC65 Gene Primary ciliary dyskinesia type 27 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Ear Nose Throat Disorders |
| Doctor | ENT Doctor |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test gene EYA18 |
| Test Details |
The CCDC65 gene is associated with primary ciliary dyskinesia type 27, a genetic disorder that affects the function of cilia in the body. Cilia are tiny, hair-like structures found on the surface of cells that play a crucial role in moving mucus and other substances in the respiratory tract, reproductive system, and other organs. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or even the entire genome. It uses high-throughput sequencing technologies to rapidly sequence and analyze DNA samples. A CCDC65 gene NGS genetic test involves sequencing the CCDC65 gene to identify any variations or mutations that may be present. This test can help diagnose primary ciliary dyskinesia type 27 and provide valuable information about the specific genetic cause of the condition. Genetic testing for primary ciliary dyskinesia can be helpful for individuals who have symptoms suggestive of the disorder or those with a family history of the condition. It can aid in confirming a diagnosis, guiding treatment decisions, and providing information about the risk of passing on the condition to future generations. |
